Literature DB >> 23330735

Advancing pluripotent stem cell culture: it is a matter of setting the standard.

Peter Sartipy1.   

Abstract

Human pluripotent stem cells (hPSCs), defined by their ability to proliferate indefinitely and the capacity to differentiate into all tissue cell types of the adult, represent a platform for the realization of breakthrough technologies for industrial and regenerative medicine applications. We have witnessed tremendous developments over the last decade related to methods for establishment, maintenance, differentiation, and applications of hPSCs and their derivatives. Despite all progress made in the hPSC field, there are still fundamental issues yet to be resolved. For example, our understanding of the pluripotent state remains limited, which in turn may have substantial consequences on how we interpret and communicate scientific data concerning hPSCs. This brief commentary aims to highlight recent important findings that demonstrate additional levels of complexity to the current assessment of pluripotent stem cell cultures. In addition, these data may help to provide some explanations for the challenges in reproducing hPSC differentiation protocols across laboratories.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23330735      PMCID: PMC3613963          DOI: 10.1089/scd.2012.0668

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  8 in total

1.  Distinct lineage specification roles for NANOG, OCT4, and SOX2 in human embryonic stem cells.

Authors:  Zheng Wang; Efrat Oron; Brynna Nelson; Spiro Razis; Natalia Ivanova
Journal:  Cell Stem Cell       Date:  2012-04-06       Impact factor: 24.633

2.  Identification and classification of chromosomal aberrations in human induced pluripotent stem cells.

Authors:  Yoav Mayshar; Uri Ben-David; Neta Lavon; Juan-Carlos Biancotti; Benjamin Yakir; Amander T Clark; Kathrin Plath; William E Lowry; Nissim Benvenisty
Journal:  Cell Stem Cell       Date:  2010-10-08       Impact factor: 24.633

Review 3.  Progress made in the reprogramming field: new factors, new strategies and a new outlook.

Authors:  Samer M I Hussein; Andras A Nagy
Journal:  Curr Opin Genet Dev       Date:  2012-09-05       Impact factor: 5.578

4.  Passaging and colony expansion of human pluripotent stem cells by enzyme-free dissociation in chemically defined culture conditions.

Authors:  Jeanette Beers; Daniel R Gulbranson; Nicole George; Lauren I Siniscalchi; Jeffrey Jones; James A Thomson; Guokai Chen
Journal:  Nat Protoc       Date:  2012-10-25       Impact factor: 13.491

5.  Comparison of defined culture systems for feeder cell free propagation of human embryonic stem cells.

Authors:  Veronika Akopian; Peter W Andrews; Stephen Beil; Nissim Benvenisty; Jennifer Brehm; Megan Christie; Angela Ford; Victoria Fox; Paul J Gokhale; Lyn Healy; Frida Holm; Outi Hovatta; Barbara B Knowles; Tenneille E Ludwig; Ronald D G McKay; Takamichi Miyazaki; Norio Nakatsuji; Steve K W Oh; Martin F Pera; Janet Rossant; Glyn N Stacey; Hirofumi Suemori
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-02-26       Impact factor: 2.416

6.  Optimized protocol for derivation of human embryonic stem cell lines.

Authors:  María Vicenta Camarasa; Víctor Miguel Galvez; Daniel Roy Brison; Daniel Bachiller
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

7.  Endogenous Wnt signalling in human embryonic stem cells generates an equilibrium of distinct lineage-specified progenitors.

Authors:  Timothy A Blauwkamp; Shelly Nigam; Reza Ardehali; Irving L Weissman; Roel Nusse
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

8.  Characterization of human embryonic stem cell lines by the International Stem Cell Initiative.

Authors:  Oluseun Adewumi; Behrouz Aflatoonian; Lars Ahrlund-Richter; Michal Amit; Peter W Andrews; Gemma Beighton; Paul A Bello; Nissim Benvenisty; Lorraine S Berry; Simon Bevan; Barak Blum; Justin Brooking; Kevin G Chen; Andre B H Choo; Gary A Churchill; Marie Corbel; Ivan Damjanov; Jon S Draper; Petr Dvorak; Katarina Emanuelsson; Roland A Fleck; Angela Ford; Karin Gertow; Marina Gertsenstein; Paul J Gokhale; Rebecca S Hamilton; Ales Hampl; Lyn E Healy; Outi Hovatta; Johan Hyllner; Marta P Imreh; Joseph Itskovitz-Eldor; Jamie Jackson; Jacqueline L Johnson; Mark Jones; Kehkooi Kee; Benjamin L King; Barbara B Knowles; Majlinda Lako; Franck Lebrin; Barbara S Mallon; Daisy Manning; Yoav Mayshar; Ronald D G McKay; Anna E Michalska; Milla Mikkola; Masha Mileikovsky; Stephen L Minger; Harry D Moore; Christine L Mummery; Andras Nagy; Norio Nakatsuji; Carmel M O'Brien; Steve K W Oh; Cia Olsson; Timo Otonkoski; Kye-Yoon Park; Robert Passier; Hema Patel; Minal Patel; Roger Pedersen; Martin F Pera; Marian S Piekarczyk; Renee A Reijo Pera; Benjamin E Reubinoff; Allan J Robins; Janet Rossant; Peter Rugg-Gunn; Thomas C Schulz; Henrik Semb; Eric S Sherrer; Henrike Siemen; Glyn N Stacey; Miodrag Stojkovic; Hirofumi Suemori; Jin Szatkiewicz; Tikva Turetsky; Timo Tuuri; Steineke van den Brink; Kristina Vintersten; Sanna Vuoristo; Dorien Ward; Thomas A Weaver; Lesley A Young; Weidong Zhang
Journal:  Nat Biotechnol       Date:  2007-06-17       Impact factor: 54.908

  8 in total
  2 in total

1.  One Standardized Differentiation Procedure Robustly Generates Homogenous Hepatocyte Cultures Displaying Metabolic Diversity from a Large Panel of Human Pluripotent Stem Cells.

Authors:  Annika Asplund; Arvind Pradip; Mariska van Giezen; Anders Aspegren; Helena Choukair; Marie Rehnström; Susanna Jacobsson; Nidal Ghosheh; Dorra El Hajjam; Sandra Holmgren; Susanna Larsson; Jörg Benecke; Mariela Butron; Annelie Wigander; Karin Noaksson; Peter Sartipy; Petter Björquist; Josefina Edsbagge; Barbara Küppers-Munther
Journal:  Stem Cell Rev Rep       Date:  2016-02       Impact factor: 5.739

Review 2.  Employment of the Triple Helix concept for development of regenerative medicine applications based on human pluripotent stem cells.

Authors:  Peter Sartipy; Petter Björquist
Journal:  Clin Transl Med       Date:  2014-05-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.